Your browser doesn't support javascript.
loading
Establishment of a novel diagnostic test algorithm for human T-cell leukemia virus type 1 infection with line immunoassay replacement of western blotting: a collaborative study for performance evaluation of diagnostic assays in Japan.
Okuma, Kazu; Kuramitsu, Madoka; Niwa, Toshihiro; Taniguchi, Tomokuni; Masaki, Yumiko; Ueda, Gohzoh; Matsumoto, Chieko; Sobata, Rieko; Sagara, Yasuko; Nakamura, Hitomi; Satake, Masahiro; Miura, Kiyonori; Fuchi, Naoki; Masuzaki, Hideaki; Okayama, Akihiko; Umeki, Kazumi; Yamano, Yoshihisa; Sato, Tomoo; Iwanaga, Masako; Uchimaru, Kaoru; Nakashima, Makoto; Utsunomiya, Atae; Kubota, Ryuji; Ishitsuka, Kenji; Hasegawa, Hiroo; Sasaki, Daisuke; Koh, Ki-Ryang; Taki, Mai; Nosaka, Kisato; Ogata, Masao; Naruse, Isao; Kaneko, Noriaki; Okajima, Sara; Tezuka, Kenta; Ikebe, Emi; Matsuoka, Sahoko; Itabashi, Kazuo; Saito, Shigeru; Watanabe, Toshiki; Hamaguchi, Isao.
Afiliação
  • Okuma K; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Kuramitsu M; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Niwa T; Research and Development Division, Fujirebio Inc., Tokyo, Japan.
  • Taniguchi T; Protein Technology, Engineering 1, Sysmex Corporation, Kobe, Japan.
  • Masaki Y; Roche Diagnostics K.K., Tokyo, Japan.
  • Ueda G; Abbott Japan LLC, Tokyo, Japan.
  • Matsumoto C; Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
  • Sobata R; Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
  • Sagara Y; Department of Quality, Japanese Red Cross Kyushu Block Blood Center, Fukuoka, Japan.
  • Nakamura H; Department of Quality, Japanese Red Cross Kyushu Block Blood Center, Fukuoka, Japan.
  • Satake M; Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
  • Miura K; Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Fuchi N; Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Masuzaki H; Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Okayama A; Department of Rheumatology, Infectious Diseases and Laboratory Medicine, University of Miyazaki, Miyazaki, Japan.
  • Umeki K; Department of Rheumatology, Infectious Diseases and Laboratory Medicine, University of Miyazaki, Miyazaki, Japan.
  • Yamano Y; Department of Medical Life Science, Kyushu University of Health and Welfare, Miyazaki, Japan.
  • Sato T; Division of Neurology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Iwanaga M; Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Uchimaru K; Department of Rare Diseases Research, Institute of Medical Science, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Nakashima M; Department of Clinical Epidemiology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  • Utsunomiya A; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
  • Kubota R; Department of Hematology and Oncology, Research Hospital, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Ishitsuka K; Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.
  • Hasegawa H; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Sasaki D; Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
  • Koh KR; Department of Hematology and Rheumatology, Kagoshima University, Kagoshima, Japan.
  • Taki M; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Nosaka K; Department of Laboratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  • Ogata M; Department of Hematology, Osaka General Hospital of West Japan Railway Company, Osaka, Japan.
  • Naruse I; Rakuwakai Kyoto Medical Examination Center, Kyoto, Japan.
  • Kaneko N; Department of Hematology, Kumamoto University of Medicine, Kumamoto, Japan.
  • Okajima S; Department of Hematology, Oita University Hospital, Oita, Japan.
  • Tezuka K; Department of Infection and Immunology, SRL Inc., Tokyo, Japan.
  • Ikebe E; Department of Infection and Immunology, SRL Inc., Tokyo, Japan.
  • Matsuoka S; Department of Infection and Immunology, SRL Inc., Tokyo, Japan.
  • Itabashi K; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Saito S; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Watanabe T; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Hamaguchi I; Department of Pediatrics, Showa University School of Medicine, Tokyo, Japan.
Retrovirology ; 17(1): 26, 2020 08 24.
Article em En | MEDLINE | ID: mdl-32831150

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Algoritmos / Vírus Linfotrópico T Tipo 1 Humano / Infecções por HTLV-I / Testes Diagnósticos de Rotina Tipo de estudo: Diagnostic_studies / Evaluation_studies / Prognostic_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Algoritmos / Vírus Linfotrópico T Tipo 1 Humano / Infecções por HTLV-I / Testes Diagnósticos de Rotina Tipo de estudo: Diagnostic_studies / Evaluation_studies / Prognostic_studies Limite: Humans País como assunto: Asia Idioma: En Ano de publicação: 2020 Tipo de documento: Article